S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Why did Biden repeal Trump's Executive Order?! (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The End of America (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
Buy THIS stock before Taiwan is attacked... (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Why did Biden repeal Trump's Executive Order?! (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The End of America (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
Buy THIS stock before Taiwan is attacked... (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Why did Biden repeal Trump's Executive Order?! (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The End of America (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
Buy THIS stock before Taiwan is attacked... (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Why did Biden repeal Trump's Executive Order?! (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The End of America (Ad)
Italy's premier visits Libya for talks on energy, migration
Japan firm opens whale meat vending machines to push sales
Buy THIS stock before Taiwan is attacked... (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Online system to seek asylum in US is quickly overwhelmed
NASDAQ:ANIX

Anixa Biosciences - ANIX News Today

$4.46
+0.05 (+1.13%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.31
$4.62
50-Day Range
$3.78
$5.04
52-Week Range
$2.30
$6.25
Volume
44,601 shs
Average Volume
38,099 shs
Market Capitalization
$137.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.



ANIX Media Mentions By Week

ANIX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANIX
News Sentiment

0.95

0.71

Average
Medical
News Sentiment

ANIX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANIX Articles
This Week

2

0

ANIX Articles
Average Week

SourceHeadline
finance.yahoo.com logoAre Investors Undervaluing Anixa Biosciences, Inc. (NASDAQ:ANIX) By 38%?
finance.yahoo.com - January 24 at 10:21 AM
finance.yahoo.com logoAnixa Biosciences, Inc. (NASDAQ:ANIX): Is Breakeven Near?
finance.yahoo.com - December 28 at 8:46 AM
finance.yahoo.com logoAnixa Biosciences to Present at Biotech Showcase 2023
finance.yahoo.com - December 19 at 10:06 AM
reuters.com logoAnixa Biosciences Inc
reuters.com - December 17 at 11:14 PM
finance.yahoo.com logoAnixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
finance.yahoo.com - December 8 at 9:33 AM
finance.yahoo.com logoAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
finance.yahoo.com - November 8 at 11:50 AM
finance.yahoo.com logoDr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy
finance.yahoo.com - October 31 at 10:35 AM
finance.yahoo.com logoWhat Makes ANIXA BIOSCIENCES INC (ANIX) a Good Fit for "Trend Investing"
finance.yahoo.com - October 28 at 1:13 PM
finance.yahoo.com logoAnixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
finance.yahoo.com - October 26 at 9:23 AM
seekingalpha.com logoANIX Anixa Biosciences, Inc.
seekingalpha.com - October 11 at 1:42 PM
finance.yahoo.com logoAnixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - October 10 at 12:39 PM
finance.yahoo.com logoAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposium
finance.yahoo.com - September 12 at 10:49 AM
msn.com logoAnixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
msn.com - August 15 at 10:51 AM
finance.yahoo.com logoAnixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
finance.yahoo.com - August 15 at 10:51 AM
nasdaq.com logoAnixa Publishes Scientific Paper On Preventative Ovarian Cancer Technology
nasdaq.com - June 21 at 10:55 AM
finance.yahoo.com logoAnixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
finance.yahoo.com - June 21 at 9:32 AM
finance.yahoo.com logoAnixa Biosciences, Inc. (ANIX)
finance.yahoo.com - June 16 at 12:55 AM
finance.yahoo.com logoAnixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Business
finance.yahoo.com - May 18 at 7:34 AM
seekingalpha.com logoAnixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times
seekingalpha.com - May 11 at 2:01 PM
finance.yahoo.com logoHas Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - May 2 at 12:03 PM
finance.yahoo.com logoAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - April 28 at 8:42 AM
finance.yahoo.com logoAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022
finance.yahoo.com - April 6 at 11:55 AM
seekingalpha.com logoAnixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapy
seekingalpha.com - March 30 at 5:47 PM
finance.yahoo.com logoAnixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Center
finance.yahoo.com - March 30 at 5:47 PM
fool.com logoAnixa Biosciences, Inc.(ANIX)
fool.com - March 18 at 7:35 AM
finance.yahoo.com logoAnixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC
finance.yahoo.com - March 17 at 4:16 PM
nasdaq.com logoPre-market Movers: HUSA, BBBY, NINE, IMPP, MXC…
nasdaq.com - March 7 at 10:36 AM
finance.yahoo.com logoAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine
finance.yahoo.com - January 25 at 12:40 PM
seekingalpha.com logoAnixa says new protease inhibitor trumps main agent in Pfizer’s COVID-19 pill
seekingalpha.com - January 24 at 9:53 AM
finance.yahoo.com logoAnixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitor
finance.yahoo.com - January 24 at 8:54 AM
nasdaq.com logoAnixa Biosciences Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - January 6 at 8:08 AM
finance.yahoo.com logoAnixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conference
finance.yahoo.com - December 16 at 9:32 AM
benzinga.com logoAnixa Biosciences, MolGenie Report Their COVID-19 Compounds Expected To Be Effective Against Omicron Variant
benzinga.com - December 7 at 2:31 PM
markets.businessinsider.com logoAnixa : COVID-19 Compounds Expected To Be Effective Against Omicron And Delta Variants
markets.businessinsider.com - December 7 at 10:08 AM
finance.yahoo.com logoAnixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variant
finance.yahoo.com - December 7 at 9:30 AM
nasdaq.com logoThe First Human Trial of a Prevenative Breast Cancer Vaccine
nasdaq.com - October 28 at 6:55 PM
msn.com logoTrial launched for first-ever vaccine to prevent breast cancer
msn.com - October 27 at 3:15 PM
msn.com logoCleveland Clinic begins new clinical trial for vaccine aimed at stopping aggressive breast cancer
msn.com - October 26 at 9:47 AM
finance.yahoo.com logoAnixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Study
finance.yahoo.com - October 26 at 9:47 AM
finance.yahoo.com logoAnixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology
finance.yahoo.com - October 6 at 1:02 PM
finance.yahoo.com logoAnixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy
finance.yahoo.com - October 1 at 11:55 AM
finance.yahoo.com logoAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
finance.yahoo.com - September 14 at 10:25 AM
finance.yahoo.com logoAnixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 8 at 8:47 AM
finance.yahoo.com logoAnixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer
finance.yahoo.com - September 7 at 12:51 PM
finance.yahoo.com logoAnixa (ANIX) Ovarian Cancer CAR-T Drug to Enter Clinical Study
finance.yahoo.com - August 31 at 5:00 PM
msn.com logoBRIEF-Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trial
msn.com - August 30 at 3:57 PM
nasdaq.com logoAnixa Biosciences Says FDA Clears IND For CAR-T Immunotherapy For Ovarian Cancer - Quick Facts
nasdaq.com - August 30 at 3:57 PM
marketwatch.com logoAnixa Biosciences Shares Rise 5% After FDA Approves Cancer Therapy
marketwatch.com - August 30 at 3:57 PM
finance.yahoo.com logoAnixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy
finance.yahoo.com - August 30 at 3:57 PM
finance.yahoo.com logoAnixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variant
finance.yahoo.com - August 25 at 9:39 PM
Get Anixa Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ANIX) was last updated on 1/28/2023 by MarketBeat.com Staff